<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03276793</url>
  </required_header>
  <id_info>
    <org_study_id>2017P000514</org_study_id>
    <nct_id>NCT03276793</nct_id>
  </id_info>
  <brief_title>Brain Connectivity in Depression</brief_title>
  <official_title>Using Human Brain Connectivity to Identify the Causal Neuroanatomical Substrate of Depression Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beth Israel Deaconess Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will include 60 subjects with medication-refractory depression undergoing&#xD;
      transcranial magnetic stimulation (TMS) to the left dorsal lateral prefrontal cortex (DLPFC).&#xD;
      In order to obtain good quality data and account for attrition, 80 subjects will be&#xD;
      recruited. Subjects will be recruited from the Clinical Program of FDA approved TMS at the&#xD;
      Berenson-Allen Center and the Butler TMS Clinic (40 per site). Subjects will undergo an&#xD;
      hour-long MRI scanning session, an optional DNA-sample collection, up to three 20 minute&#xD;
      neuronavigation sessions for marking the site of TMS stimulation, questionnaires, and a&#xD;
      behavioral testing battery before and after their TMS treatment course. The task battery will&#xD;
      last 45-60 minutes and consist of the Emotion Conflict Resolution (ECR) task, Multi-Source&#xD;
      Interference Task (MSIT), War Game (Gambling) task, and Associative Learning with Reversal&#xD;
      task. Subjects' scores on the Hamilton Depression Rating Scale (HDRS) and Beck Depression&#xD;
      Inventory (BDI) will also be assessed before and after the TMS course. MRI data will be&#xD;
      utilized to identify brain regions whose connectivity to the stimulation site co-varies with&#xD;
      the aforementioned objective measures of symptom improvement.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 3, 2018</start_date>
  <completion_date type="Anticipated">October 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prediction of rTMS clinical response</measure>
    <time_frame>1 year after study completion</time_frame>
    <description>Connectivity between each patient's stimulation site and the subgenual cingulate will be used to predict clinical response to rTMS</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>MRI and behavioral assessment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will undergo an hour-long MRI scanning session, a marking for the site of planned clinical TMS stimulation and a behavioral testing battery before and after their TMS treatment course.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MRI scan</intervention_name>
    <description>Patients will undergo an MRI scan</description>
    <arm_group_label>MRI and behavioral assessment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral testing</intervention_name>
    <description>Patients will complete a series of cognitive tasks</description>
    <arm_group_label>MRI and behavioral assessment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female&#xD;
&#xD;
          2. Aged 18-70.&#xD;
&#xD;
          3. Have previously received or will receive TMS to the left dorsal-lateral prefrontal&#xD;
             cortex as part of the clinical treatment program at the Berenson-Allen Center for&#xD;
             Non-invasive Brain Stimulation at Beth Israel Deaconess Medical Center, or at Butler&#xD;
             Hospital for treatment of medication resistant depression&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Any current or past history of a major psychiatric illness other than depression (e.g.&#xD;
             bipolar affective disorder, schizophrenia, obsessive compulsive disorder,&#xD;
             post-traumatic stress disorder, generalized anxiety disorder)&#xD;
&#xD;
          2. Any significant current neurological illness (e.g. a history of seizures or&#xD;
             unexplained loss of consciousness, a family history of epilepsy, signs of increased&#xD;
             intracranial pressure, previously abnormal MRI scans, parkinsonism or dementia). Of&#xD;
             note, most of these are also contraindications to receiving TMS and these patients&#xD;
             would not be enrolled in the clinical treatment program.&#xD;
&#xD;
          3. Patients who are pregnant or lactating (by menstrual history)&#xD;
&#xD;
          4. Current abuse of an illicit substance (e.g. marijuana, cocaine, heroin, hallucinogens,&#xD;
             psychostimulants)&#xD;
&#xD;
          5. Positive MRI screen that would preclude the subject from undergoing magnetic resonance&#xD;
             imaging. These include, but are not limited to any of the following:&#xD;
&#xD;
               1. Known metal in the head (such as a surgical aneurysm clip), or a history of prior&#xD;
                  neurosurgical procedures&#xD;
&#xD;
               2. Ferromagnetic bioimplants activated by any electronic, mechanical or magnetic&#xD;
                  means such as: cochlear implants, pacemakers, medication pumps, vagal&#xD;
                  stimulators, deep brain stimulators, neurostimulators, biostimulators, or&#xD;
                  ventriculo-peritoneal shunts&#xD;
&#xD;
               3. Subjects who have or might have bullet fragments or other metal fragments&#xD;
                  (veterans or workers exposed to metal in their work environment)&#xD;
&#xD;
               4. Subjects with metallic paint (e.g. color contact lenses, tattoos, metallic&#xD;
                  eyeliner)&#xD;
&#xD;
               5. Subjects expressing significant anxiety or claustrophobia about being in the&#xD;
                  magnet.&#xD;
&#xD;
          6. Subjects that cannot adhere to the experimental protocol for any reason.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sandrine Jabbour, BS</last_name>
    <phone>617-667-1571</phone>
    <email>sjabbour2@bwh.harvard.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael D Fox, MD, PhD</last_name>
      <phone>617-732-7432</phone>
      <email>mdfox@bwh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Sandrine Jabbour, BS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael D Fox, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph J Taylor, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jing Li, BS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claudia Becker, BS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Fox, MD, PhD</last_name>
      <phone>617-667-0220</phone>
      <email>mfox3@bidmc.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Fox, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Press, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adam Stern, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ann Connor, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joanna Macone, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Molly Schineller, BS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tina Arani, BS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shobhik Chakraborty, BS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Butler Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Carpenter, MD</last_name>
      <phone>401-455-6632</phone>
      <email>linda_carpenter_md@brown.edu</email>
    </contact>
    <investigator>
      <last_name>Eric Tirrell, BS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>September 5, 2017</study_first_submitted>
  <study_first_submitted_qc>September 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 8, 2017</study_first_posted>
  <last_update_submitted>November 30, 2020</last_update_submitted>
  <last_update_submitted_qc>November 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beth Israel Deaconess Medical Center</investigator_affiliation>
    <investigator_full_name>Michael Fox</investigator_full_name>
    <investigator_title>Assistant Professor of Neurology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

